ArticleHealth economics2021
Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic.
Article in Health economics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Sleep Disturbance and Its Association With Purchasing Behavior of COVID-19 Medicine Among the Public After the Adjustment of Zero-COVID Policy in China: Results From a Web-Based Survey Study.Interactive journal of medical research · 2026Article
- Disposal practice and determinants of unused medicines among the general public in Gondar City, Northwest Ethiopia.Frontiers in public health · 2025Article
- Drug stockpiling behavior and its impact on anxiety among the general public in the early stage after the lifting of China's Zero-COVID policy: results from a web-based survey.Frontiers in pharmacology · 2025Article
- The impact of paid social Q&A on panic buying and digital hoarding at the stage of coexistence with COVID-19: The moderating role of sensitivity to pain of payment.International journal of disaster risk reduction : IJDRR · 2023Article
- Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization.Journal of economic behavior & organization · 2022Article
- Household Pharmaceutical Waste Disposal as a Global Problem-A Review.International journal of environmental research and public health · 2022Review
- Psychotropic drug purchases during the COVID-19 pandemic in Italy and their relationship with mobility restrictions.Scientific reports · 2022Article
- Article
- Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic.Health economics · 2021Article
- Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan.Frontiers in pharmacology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We analyze the timing, magnitude, and income dependence of pharmaceutical panic buying around the outbreak of the COVID-19 pandemic in Hungary. We use district-level monthly and daily administrative data on detailed categories of pharmaceutical purchases, merge them to income statistics, and estimate multilevel panel models. Our main results are as follows. First, the days of therapy (DOT) of pharmaceutical purchases increased by more than 30% in March 2020, when major lockdown measures were announced. This pattern holds for almost all categories of pharmaceuticals. Second, shortly after the panic reactions, the aggregate amount of pharmaceutical purchases returned to their preshock levels; however, the frequency of pharmacy visits decreased. Third, the panic buying reaction was significantly stronger in richer geographical areas, where-according to the daily data-people also reacted earlier to the pandemic-related news. Overall, the results suggest that panic buying of pharmaceuticals can have detrimental effects on vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.